Repeat Dose Tolerance Study of Regadenoson in Healthy Subjects
Clinical trial NCT01918995 · COMPLETED
Trial details
- NCT number
- NCT01918995
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2013-08-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.